Build your own SEO Report with our tools
Server infos
Keywords
Backlinks

Preview of the website in Thumbnail size.

Meta Keys provide information about a given Web page, most often to help search engines categorize them correctly. They are inserted into the HTML document, but are often not directly visible to a user visiting the site.

Title

Treatment for HER2 Positive Breast Cancer - PERJETA® (pertuzumab)

Description

Learn about PERJETA® (pertuzumab), a treatment for HER2-postitive metastatic breast cancer.
 What does PERJETA treat? PERJETA® (pertuzumab) is approved for use in combination with Herceptin® (trastuzumab) and docetaxel (chemotherapy) in people who have HER2-positive breast cancer that has spread to different parts of the body (metastatic) and who have not received anti-HER2 therapy or chemotherapy for metastatic breast cancer. Important Safety Information: PERJETA may cause heart problems, including those without symptoms (such as reduced heart function) and those with symptoms (such as congestive heart failure). Receiving PERJETA during pregnancy can result in the death of an unborn baby and birth defects. If you think you may be pregnant, you should contact your healthcare provider immediately. If you are exposed to PERJETA during pregnancy, you are encouraged to enroll in the MotHER Pregnancy Registry by contacting 1-800-690-6720. PERJETA should not be used in patients who are allergic to pertuzumab or to any of the ingredients in PERJETA. Other possible serious side effects of PERJETA therapy include: Infusion-related reactions, Severe allergic reactions (hypersensitivity reactions/anaphylaxis). PERJETA has only been shown to work in people with HER2-positive breast cancer. The most common side effects of PERJETA when given with Herceptin and docetaxel (chemotherapy) for treatment of breast cancer that has spread to other parts of the body (metastatic) are: Diarrhea, Hair loss, Low levels of white blood cells with or without a fever, Nausea, Feeling tired, Rash, Damage to the nerves (numbness, tingling, pain in hands/feet). You are encouraged to report side effects to Genentech and the FDA. You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555.

Keywords

perjeta, pertuzumab, her2, her2 positive, metastatic breast cancer treatment, her2 positive breast cancer treatment, perjeta treatment

Robots
Revisit-After
Author
  • Title : Several users don't like to put in their favorites too huge Titles.
  • Description : Only 160 characters are displayed by Google.
  • Robots : Not provided. You could use INDEX, NOINDEX, FOLLOW, NOFOLLOW
  • Revisit-After : Not provided. You should use 7 (days) by default.
  • Author : not provided

Content Properties provide information and statistics about the type of content provided.

Favicon
Yes
Language
Encoding
utf-8
Loading Time
4.93 seconde(s) => 7.7 kb/s
File Size
37.94 kb.
Text Size
11.14 kb.
HTML Size
26.8 kb.
Text/HTML Ratio
41.58 %
Flash
No
Frame
No
iFrame
No
  • Language : unknown.

Files Linked provide informations about the files included to build the page.

Image
19 with 10 ALT filled
Javascript
25
CSS
30
  • Alt : Not enought Alt in Image
  • Javascript : Too much files. Try to clean or cancat your files.
  • Css : Too much files. Try to clean or concat your files.

Links provided to display and browse this website.

Internal
15
External
21

Robots control whether search engine spiders are allowed to index a page or not, and whether they should follow links from a page or not.

Robots.txt
Yes
SiteMap
No

Headings highlight the important keywords by levels.

H1
1
H2
8
H3
10
H4
0
H5
0
  • H4 : You need to highlight more keywords by using this tag to increase their importance.
  • H5 : You need to highlight more keywords by using this tag to increase their importance.

MicroFormats are HTML extensions used for marking up people, organizations, events, locations, blog posts, products, reviews, resumes, recipes etc. Sites use Microformats to publish a standard API that is consumed and used by search engines, aggregators and other tools.

h-adr
0
h-card
0
h-entry
0
h-event
0
h-geo
0
h-item
0
h-product
0
h-recipe
0
h-resume
0
h-review
0
  • You should use Microformats to help search engines classify you.

Header makes browsers and search engines know about your page redirection.

WWW added
Yes
GET / HTTP/1.1
HTTP/1.0 301 Moved Permanently
Location: http://www.perjeta.com/

IP determines the server address.

IP
72.34.128.214
IP Reverse

Geolocation displays where the server Ip is located.

Country
Region
City
Postal code
Latitude
Longitude

Search Engine : Google

Page Rank
4 / 10
Backlinks
0
Indexed page
0

Search Engine : Bing

Backlinks
0
Indexed page
12

Search Engine : Alexa

Page Rank
2598447
Rank Delta
-2070236
Backlinks
36
Keywords

Directory presence

Yahoo
No
Dmoz
No

Analysis : Visitor Geolocation by Alexa.

Analysis : Regional / City interest by Google.

Analysis : Daily Traffic Rank Trend by Alexa.

AlexaRank

Analysis : Daily Reach Graph by Alexa.

Alexa Daily Reach Graph

Analysis : Unique Visitors by Compete.

Analysis : Backlinks discovery by Majestic SEO.

Analysis : Monthly Global Page Views by Quantcast.

Quantcast Graph

Analysis : Monthly People by Quantcast.

Quantcast Graph

Analysis : Web Search Interest (Worldwide, Past 12 months) by Google Trends.

Social Media displays the community presence of this domain.

Facebook
0 Likes / 0 Shares / 0 Comments
Twitter
0 Tweet(s)
Google Plus
0 Post(s)
Pinterests
0 Post(s)
Delicious
0 Post(s)
StumbleUpon
0 Post(s)
LinkedIn
1 Post(s)